You've got the platform. The question is what it's actually capable of.
Most enterprise clinical platforms underperform relative to what the investment was supposed to deliver. Not because of the technology, but because the gap between what a platform can do and how it's configured, adopted and integrated is almost never closed at go-live. Oracle Health is where that experience runs deepest, but the same judgment applies whatever's already installed.
Advisory-first engagement models.
Retainer partnerships for continuity. Focused sprints for specific problems. All designed for leaders who want outcomes, not ongoing dependency.
Fractional Strategic Partnership
For CIOs and digital leaders who want a senior partner on a retained basis: to steady the ship, sharpen decisions, and translate platform capability into board-ready narrative.
Typical cadence: 8 to 16 hours per month. Monthly governance rhythm, ad-hoc decision support, vendor oversight, and roadmap prioritisation.
Optimisation & Value-Extraction
For underperforming Oracle Health environments where adoption, workflow, performance or integration is limiting ROI.
Timebox: 4 to 8 weeks. An executable optimisation plan, quantified benefits and a prioritised backlog, not a report that sits on a shelf.
AI Operationalisation
For organisations stuck between pilots and enterprise adoption. The challenge is rarely the AI itself. It's governance, clinical safety, workflow integration, and selecting the right use cases.
Outcome: AI that is used, not shelved.
Platform Transformation
For CIOs navigating significant platform or AI investment decisions and needing an independent view before committing.
Outcome: Board-ready roadmap with executable milestones and clear ROI justification.
EMR & Platform Selection Advisory
For organisations evaluating a new EMR, replacing a legacy system, or navigating a first deployment. The advice is vendor-agnostic. There is no commercial relationship with any platform provider. Having been on the operator side of these decisions, the work covers requirements definition, vendor evaluation, contract negotiation support and implementation readiness. The goal is the right platform for your clinical and operational context, not the easiest sale.
What this looks like in practice.
A selection of outcomes from real engagements. Numbers are verifiable; the Intelligent CISO case study is publicly available. For Oracle Health-specific depth, see the dedicated Oracle Health page.
Across platform modernisation, AI programmes and revenue cycle work. Judgment calls made and defended in front of a board, not modelled in a slide deck.
Ambient AI live across a multi-site health system, with a governance model that survived the jump from pilot to production.
Medication harm prevention and TPN safety programmes built on real-time decision support. Delivered within an existing platform, no rip-and-replace required.
The deepest platform-specific proof point: a world-first Oracle Health Millennium to OCI migration with zero clinical downtime. Full detail on the Oracle Health page.
Where the practice works.
GCC
Government health systems, semi-government organisations, and private hospitals across UAE, Qatar and Saudi Arabia.
India
Multi-hospital systems and PE-backed healthcare investments. Due diligence and post-acquisition technology advisory.
APAC
Government hospital engagements and advisory work in Australia. Available for select remote engagements globally.
What technology leaders ask.
Most retainer engagements run at 8 to 16 hours per month. In practice that means a monthly governance session, availability for ad-hoc decisions when something time-sensitive comes up, vendor call support when you need an independent voice in the room, and ongoing input into roadmap and board narrative. It is structured to fit around your existing team, not replace it.
Typically 4 to 8 weeks depending on scope. The output is an executable plan with quantified benefits and a prioritised backlog, not a discovery report. Most organisations have enough data in their existing environment to move quickly. The bottleneck is usually access to the right people internally, not the analysis itself.
The King's College Hospital Dubai migration ran over several months from planning to go-live, with zero clinical downtime. Timeline depends heavily on your environment complexity, number of integrated systems, and Oracle's own project resourcing. The planning and vendor management phase is where most organisations lose time. That is typically where advisory input adds the most value.
Almost always one of three things: the use case was selected for the technology rather than the clinical need, governance and change management were treated as afterthoughts, or the workflow integration was too shallow to survive handover to the operational team. The technology itself is rarely the issue. Fixing this starts with an honest audit of where the pilot actually sits in the clinical workflow and who owns the outcome.
Yes. The advisory work covers the full technology stack including ERP, supply chain, PACS, laboratory, pharmacy, and integration architecture. Oracle Health is the deepest specialism but most of the strategic and operational challenges in healthcare technology are not EMR-specific.
A direct conversation. No RFP process, no proposal before a call. If there is a fit, the scope of a first engagement usually becomes clear quickly. If there is not, that is worth knowing early too.
Let's have a conversation.
If you have a specific challenge in mind, or want to understand whether there is a fit, a direct conversation is the right place to start.
Thank you. Your message has been sent.
You will hear back directly, usually within a couple of days.
Prefer email? rajiv.ganapathy@nirvaanadvisory.com